Results 1 to 10 of about 262,938 (292)

Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and glucocerebrosidase activity

eLife
The endolysosomal phospholipid bis(monoacylglycerol)phosphate (BMP) is aberrantly elevated in urine from Parkinson’s patients carrying mutations in leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GCase). Because BMP resides on, and regulates
Elsa Meneses-Salas, Moises Castellá, Marianna Arnold, Frank Hsieh, Rubén Fernández-Santiago, Mario Ezquerra, Alicia Garrido, María-José Martí, Carlos Enrich, Suzanne R Pfeffer, Kalpana Merchant, Albert Lu   +11 more
doaj   +1 more source

Oxidative Stress Association with Autonomic Dysfunction in Parkinson Patients

Diyala Journal of Medicine, 2019
Background: Parkinson’s disease may be caused by oxidative stress within cells due to defective nucleoli. Dopamine producing neurons are particularly sensitive to oxidative stress.
Asma'a Khalaf Hamod, Abdul Kareem Kadim AL- Khazraji, Isra'a Fayiq Ja'afer, Farqad Badar Hamdan   +3 more
doaj   +2 more sources

Adjunctive therapy in Parkinson's disease: the role of rasagiline

Neuropsychiatric Disease and Treatment, 2012
Kathryn D Gaines,1 Vanessa K Hinson21Department of Neurology, Aurora Advanced Healthcare, Milwaukee, WI, 2Department of Neurosciences, Movement Disorders Program, Medical University of South Carolina, Charleston, SC, USAAbstract: Parkinson's ...
Gaines KD, Hinson VK
doaj  

Psychiatric disorders in primary focal dystonia and in Parkinson’s disease

Neuropsychiatric Disease and Treatment, 2011
Fernando MV Dias1, Arthur Kummer1, Flávia CP Doyle2, Estefânia Harsányi1, Francisco Cardoso2, Leonardo F Fontenelle3, Antônio Lúcio Teixeira11Neuropsychiatric Branch, 2Movement Disorders Clinic ...
Fernando MV Dias, Arthur Kummer, Flávia CP Doyle, et al   +3 more
doaj  

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Neuropsychiatric Disease and Treatment, 2019
Ashish Kumar Gupta,1 Ruchika Pokhriyal,1 Uddipan Das,1 Mohd Imran Khan,1 Domada Ratna Kumar,1 Rishab Gupta,2 Rakesh Kumar Chadda,2 Rashmi Ramachandran,3 Vinay Goyal,4 Manjari Tripathi,4 Gururao Hariprasad11Department of Biophysics; 2Department of ...
Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G   +10 more
doaj  

History of Neurology: Parkinson’s Disease Before James Parkinson

Advances in Clinical Neuroscience & Rehabilitation, 2014
AJ Larner
doaj   +1 more source

Motor skills problems in Parkinson Disease

Journal of Education, Health and Sport, 2017
Parkinson Disease is one of the most common neurodegenerative disease. The average age in which PD occur is 54-58 years but the scientists note that Parkinson Disease can also appear in age of 30 or in age of 80.
Anna Maria Dobosiewicz, Szymon Kwiatkowski, Paulina Miętkowska, Agnieszka Marszałek, Sylwia Wendland   +4 more
doaj  

Digital Technologies for Symptom Monitoring in Parkinson Disease. [PDF]

Curr Neurol Neurosci Rep
Chunga N, Reddy V, Barbosa W, Adams JL.
europepmc   +1 more source

Feasibility for a Community-Based Parkinson Disease Cohort in Hawaii. [PDF]

Neurol Clin Pract
Krening E, Shuman R, Faouzi M, Thai K, Gao F, Tanner CM, Ross GW, Bruno MK.   +7 more
europepmc   +1 more source

Striatal Dopamine Transporter and Rest Tremor in Parkinson Disease: A Clinical Validation. [PDF]

Neurology
Niemi KJ, Jaakkola E, Myller EM, Eklund MRE, Nuuttila S, Mertsalmi T, Murtomäki KM, Levo R, Noponen T, Ihalainen T, Scheperjans F, Joutsa J, Kaasinen V.   +12 more
europepmc   +1 more source